ESPR icon

Esperion Therapeutics
ESPR

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$5
145% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citizens
Citizens
Jason Butler
100% 1-yr ESPR win rate
13 Mar ‘26 1 month ago
Needham
Needham
Serge Belanger
50% 1-yr ESPR win rate
3 Mar ‘26 1 month ago